Utah Medical Products Q3 EPS $1.081 Down From $1.178 YoY, Sales $12.51M Down From $12.96M YoY
Portfolio Pulse from Benzinga Newsdesk
Utah Medical Products reported Q3 earnings per share (EPS) of $1.081, down from $1.178 year-over-year (YoY). Sales also decreased to $12.51M from $12.96M YoY.
October 26, 2023 | 1:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Utah Medical Products' Q3 earnings and sales have both decreased YoY. This could potentially impact investor sentiment and the company's stock price.
Earnings reports are a key indicator of a company's financial health. A decrease in both EPS and sales YoY suggests that Utah Medical Products may be facing some financial challenges, which could negatively impact investor sentiment and lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100